InvestDayTip
Back to the main list

EMREmerson Electric Company

# 85 · $161.59 (+0.81%) · $90.13B · Industrials

51.8

52-week range

$91.92$163.82

Market data

P/E
35.36
1M
+3.49%
1Y
+23.23%
Yield
1.37%
RSI
48.12
MACD
-0.16%

Breakdown

Value29
Growth54
Profitability58
Momentum74
EPS Revisions55

Why

  • earnings growth of 16.5%
  • margin and ROA expanding YoY
  • 12-1 momentum return of 19.1%
  • trading 10.8% above 200d SMA

Rationale is generated by the scoring engine (English).

Piotroski F-Score

7

7 / 9 checks passed

  • roa positive
  • ocf positive
  • roa improving
  • accruals
  • leverage decreasing
  • liquidity improving
  • no dilution
  • margin improving
  • turnover improving

Altman Z-Score

2.57Grey zone

Risk signals

  • Altman Z in grey zoneMedium

    Z-Score 2.57 (1.81–2.99) — not clearly safe

  • Rising leverageInfo

    debt/assets higher than the previous fiscal year

  • Product revenue concentrationInfo

    69% of revenue from Intelligent Devices

Company research

Business Overview Emerson Electric Co. (EMR) is a global industrial automation company that sells automation systems, control software, industrial AI/analytics, and measurement/sensing and final control hardware (e.g., valves, actuators, instrumentation) primarily to industrial customers, monetized through product sales, software licensing/subscriptions, and services/support. It reports major operations across Software & Systems and Intelligent Devices (and also Safety & Productivity), serving process, hybrid, and discrete end markets. Market Position Emerson positions itself as a global automation leader with a large installed base and an increasingly software-defined technology stack (including DeltaV™, Ovation™, and AspenTech software), which supports recurring software and lifecycle services alongside hardware content. Key Segments Software & Systems combines Control Systems & Software and Test & Measurement (NI), while Intelligent Devices includes Sensors (e.g., Rosemount, Micro Motion) and Final Control (e.g., Fisher, ASCO, Bettis).

AI-generated summary based on third-party data; it may contain errors. Not investment advice or a recommendation to invest.

Revenue
Revenue · 2021–2025 · $12.93B → $18.02B$18.02B
Gross margin
Gross margin · 2021–2025 · 0.6% → 0.5%0.5%
Operating margin
Operating margin · 2021–2025 · 0.3% → 0.2%0.2%
Net margin
Net margin · 2021–2025 · 0.2% → 0.1%0.1%
FCF / Net income
FCF / Net income · 2021–2025 · 1.38 → 1.161.16
OCF / Net income
OCF / Net income · 2021–2025 · 1.55 → 1.351.35
Debt / Equity
Debt / Equity · 2021–2025 · 0.73 → 0.680.68
Current ratio
Current ratio · 2021–2025 · 1.35 → 0.880.88

Period: 2021-09-30 → 2025-09-30